Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 2, 1997, Pages 165-170

  Garrett, Jeffrey E ^a   Town, G Ian ^b   Rodwell, Peter ^c   Kelly, Ann Marie ^d,e  

^a GREEN LANE HOSPITAL   (New Zealand)

^b Canterbury Resp Research Group   (New Zealand)

^c MIDDLEMORE HOSPITAL   (New Zealand)

^d WESTERN HOSPITAL   (Australia)

^e CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Acute severe asthma; Ipratropium bromide; Salbutamol

Indexed keywords

IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; SALBUTAMOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; NEBULIZATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030790334     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70219-7     Document Type: Article

References (25)

1. British Thoracic Society. Guidelines for management of asthma. Thorax 1993;48:S1-24.
2. Asthma Management Handbook 1996. National Asthma Campaign Ltd. Australia, p. 32-5.
3. Roeseler J. Reynaert MS. A comparison of fenoterol and fenoterolipratropium nebulisation treatment in acute asthma. Acta Therapeutica 1987;13:571-6.
4. O'Driscoll BR, Taylor RJ, Horsley MG, Chambers DK, Bernstein A. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet 1989;1:1418-20.
5. Watson WTA, Becker AB, Simons FER. Comparison of ipratropium solution, fenoterol solution and their combination administered by nebulizer and free mask to children with acute asthma. J Allergy Clin Immunol 1988;82:1012-8.
6. Rebuck AS. Chapman KR, Aboud R, Pare PD, Kreisman H, Wolkove N, Vickerson F. Nebulised anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med 1987;82:59-64.
7. Leahy B, Gomm SA, Cullen SC. Comparison of nebulised salbutamol with nebulised ipratropium bromide in acute asthma. Br J Dis Chest 1983;77:159-63.
8. Higgins RM. Stradling JR, Lane DM. Should ipratropium bromide be added to beta-agonists in the treatment of acute severe asthma? Chest 1988;94:718-22.
9. Summers QA, Tarala R. Nebulised ipratropium in the treatment of acute asthma. Chest 1990;97:430-4.
10. Ward MJ, Fentem PH, Smith WHR, Davies D. Ipratropium bromide in acute asthma. Br Med J 1981;282:598-600.
11. Bryant D. Nebulised ipratropium bromide in the treatment of acute asthma. Chest 1988;88:24-8.
12. Ward MJ. The role of anticholinergic drugs in acute asthma. In: Cross NJ: editor. Anticholinergic therapy in obstructive airways disease. London: Franklin Scientific Publications; 1993. p. 155-62.
13. Rossing TH, Fanta CH, McFadden ER. A controlled trial of the use of single versus combined drug therapy in the treatment of acute episodes of asthma. Am Rev Respir Dis 1981;123:190-4.
14. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
15. Enright PL, Johnson LR, Connett JE, Voelker H, Buist AS. Spirometry in the Lung Health Study. 1. Methods and quality control. Am Rev Respir Dis 1991;143:1215-23.
16. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123:659-64.
17. Macfie AE, Harris EA, Whitlock RML. The maximal expiratory flow/volume curve in 197 healthy New Zealanders: a comparison with recent American standards. Aust N Z J Med 1981;11:517-21.
18. Gardner RM, Hunkinson JL, Clausen JE, Crapo RO, Epler GR. Standardization of spirometry: 1987 update. Official statement of the American Thoracic Society. Am Rev Respir Dis 1987;136:1285-98.
19. Garrett J, Frankel A, Lanes S, Rodwell P, Kelly AM, Town GI. Factors predicting severity and response to therapy in acute asthma [abstract]. Am J Respir Crit Care Med 1995;151:A380.
20. Boe J, Ljungholm K. Drug intake and plasma concentrations in acute asthma. Respiration 1984;45:430-7.
21. Fanta CH, Rossing TH, McFadden ER. Emergency treatment of asthma. Am Med J 1982;72:416-22.
22. Rossing TH, Fanta CH, McFadden ER. The effect of outpatient treatment of asthma with beta-agonists on the response to sympathomimetics in an emergency room. Am J Med 1983;75:781-4.
23. Boe J, Carlsson LG, Hetta L, Karlson B. Ljungholm K. Acute asthma-plasma levels and effect of terbutaline IV injections. Eur J Respir Dis 1985;67:261-8.
24. Janson C, Boe J, Boman G, Mossberg B, Svedmyr N. Bronchodilator intake and plasma levels on admission for severe acute asthma. Eur Respir J 1992;5:80-5.
25. Barns P, Belvisi MG, Mak JCW, Haddad EB, O'Connor B. Tiotropium bromide, a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease. Life Sci 1995;56: 853-9.